A PHASE III INVESTIGATOR-INITIATED CLINICAL TRIAL COMPARING REMIMAZOLAM WITH PLACEBO FOR SADATION IN JAPANESE PATIENTS UNDERGOING UPPER GASTROINTESTINAL ENDOSCOPY

Mitsuru Esaki  1, 2     Ryoji Ichijima  3, 4     Hisatomo Ikehara  4, 5     Daisuke Yamaguchi  6     Yasuhiko Nagata  7     Kanako Ogura  4, 7     Yosuke Minoda  7     Hiroyuki Ono  8     Yuki Maeda  8     Shinsuke Kiriyama  8     Unknown Unknown  9     Yuichi Kanmura  10     Takuji Gotoda  10    
1 Harasanshin Hospital, Fukuoka, Japan
2 Kyushu University, Fukuoka, Japan
3 Kiriyama Clinic, Takasaki, Japan
4 Nihon University School of Medicine, Tokyo, Japan
5 Kitasato University School of Medicine, Sagamihara, Japan
6 National Hospital Organization Ureshino Medical Center, Ureshino, Japan
7 Nagata Surgery and Gastroenterological Clinic, Nishitokyo-shi, Japan
8 Shizuoka Cancer Center, Shizuoka, Japan
9 Tonan Hospital, Hokkaido, Japan
10 Fujimoto General Hospital, Miyazaki, Japan

Topic
Oesophagus

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing